overview
observations-included
summary-by-condition
summary-by-class
summmary-by-intervention
comparisons
pain-intensity-continuous-measure
pain-intensity-snri
direct-evidence-for-snri-in-pain-intensity
ssri-pain-intensity
no-direct-evidence-for-ssri-in-pain-intensity
pain-intensity-and-tca
pain-intensity-only-direct-evidence-for-amitriptyline
substantial-pain-50-reduction
do-nma-results-for-snri-differ-from-pairwise-comparisons
substantial-pain-do-the-results-differ-for-fibromyalgia
substantial-pain-do-the-results-differ-for-musculoskeletal
substantial-pain-do-the-results-differ-for-neuropathic
is-there-a-difference-in-results-for-dose-substantial-pain
does-desvenlafaxine-show-the-same-attributes
do-results-agree-for-milnacipran
a-final-look-at-overall-results-for-substantial-pain
moderate-pain-30-reduction
mood
mood-1
snri-and-mood
first-well-look-at-duloxetine-and-then-the-other-results
physical-function
condition-all-conditions
antidepressant-change-score-all-classes-all-doses
antidepressant-post-intervention-all-classes-all-doses
antidepressant-change-score-all-classes-high
antidepressant-change-score-all-classes-low
antidepressant-change-score-all-classes-standard
antidepressant-post-intervention-all-classes-standard
antidepressant-change-score-snri-all-doses
antidepressant-post-intervention-snri-all-doses
antidepressant-post-intervention-tca-all-doses
condition-fibromyalgia
antidepressant-post-intervention-all-classes-all-doses-1
antidepressant-change-score-all-classes-all-doses-1
condition-musculoskeletal
antidepressant-change-score-all-classes-all-doses-2
antidepressant-post-intervention-all-classes-all-doses-2
condition-neuropathic
antidepressant-change-score-all-classes-all-doses-3
sleep
quality-of-life
adverse-events
adverse-events-1
adverse-events-and-snri
only-post-intervention-results
pair-wise-comparisons
adverse-events-tca
direct-evidence-for-tca-with-adverse-events
no-pairwise-analyses-available-for-ssri
no-direct-evidence-for-adverse-events-by-condition
adverse-events-and-dose
adverse-events-for-duloxetine-by-dose
adverse-events-and-conditions
adverse-events-and-fibromyalgia
adverse-events-and-musculoskeletal
adverse-events-in-patients-with-neuropathic-conditions
a-final-look-at-overall-results
withdrawal
duloxetine
documentation
calculations-for-missing-observations
direction-of-improvement
are-the-converted-values-similar-to-the-raw-values
number-of-studies-extracted-175
excluded-observations-26-from-7-studies
random-sample-checked
pipeline
getting-data
